Changes in emotions related to medication used to treat ADHD. Part II: clinical approaches. - Wikidata - wikimedia - TriplyDB

Changes in emotions related to medication used to treat ADHD. Part II: clinical approaches.

Changes in emotions related to medication used to treat ADHD. Part II: clinical approaches.

http://www.wikidata.org/entity/Q37790840

about

Obsessive-compulsive disorder and comorbid attention-deficit/hyperactivity disorder: a complex diagnostic disentanglement and treatment.Validation of the Expression and Emotion Scale for Children with attention deficit hyperactivity disorder into Brazilian Portuguese.Bupropion for attention deficit hyperactivity disorder (ADHD) in adults.

P2860

Q37111476-0E01CD5A-841A-4A8C-BB17-C84E7E235D0A Q38622319-0779A4B6-B865-40AC-88C1-B24F5E50A54B Q43075919-126E68A8-3DE9-49FD-B9D2-6FEAA758C221

P2860

Changes in emotions related to medication used to treat ADHD. Part II: clinical approaches.

http://www.wikidata.org/entity/Q37790840

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 September 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Changes in emotions related to ...... Part II: clinical approaches.

@en

Changes in emotions related to ...... Part II: clinical approaches.

@nl

type

label

Changes in emotions related to ...... Part II: clinical approaches.

@en

Changes in emotions related to ...... Part II: clinical approaches.

@nl

prefLabel

Changes in emotions related to ...... Part II: clinical approaches.

@en

Changes in emotions related to ...... Part II: clinical approaches.

@nl

P1433

Q37790840-8DD4CDE9-C83D-4460-BA4A-6B4FFADF473F

P1476

Q37790840-1355E76F-3A71-40AC-B2FE-DC5B95E42CCF

P2093

Q37790840-21C02D7A-4176-4502-9389-823EB8F02918

Q37790840-6A88FF45-0EE9-4D7F-B7A5-36E95D04D547

Q37790840-7D7B24EE-EA38-4D65-B1FD-DB3A0F772FF9

Q37790840-97CF6A05-0DB7-4EEC-8233-55E56E586CB8

Q37790840-DAA9086F-D2F1-49B6-A94A-1F20C90D27B9

P2860

Q37790840-0702C9D5-7AF4-4A2A-966E-92A5E64EECAC

Q37790840-4DCC5B53-2154-48A9-BF45-FC0C11360F2B

Q37790840-535823AA-821C-48A6-91B0-78788DE462EA

Q37790840-566CAFDB-4AEF-46E9-9121-EABF9D68A258

Q37790840-5A130108-9EB8-4865-870E-B1FC43C96BF8

Q37790840-6D0271E3-E5FB-4226-9DC2-96C359C1AF0F

Q37790840-964E4FA4-1B8F-4BDB-81E0-341323986109

Q37790840-9D8EE6B1-2128-4762-8621-BD782B297F09

Q37790840-CB6CB5E7-9118-4F08-BCCC-19B11307F354

Q37790840-DE1F68D5-2809-4738-AE2A-88A0C7AAC39D

P304

Q37790840-1363B491-ECEF-40F3-BE08-7B86C301D2E3

P31

Q37790840-28796655-85E3-435A-A6CC-8AB2D73CA725

P356

Q37790840-754E5463-55E3-4B63-9756-F7CF20163CB9

P433

Q37790840-1B8EFB64-11DF-45A3-9A22-AF43BA9F2ED6

P478

Q37790840-F384D280-CBF5-46CA-92B2-6ECE5306DD98

P50

Q37790840-0309CCB5-C17B-40DB-A30C-A87B0E65DE62

P577

Q37790840-D00EC8E8-E8F0-4203-9C12-1BD366C1D21D

P5875

Q37790840-E05E7237-20BE-4BC1-9F9A-8C6F90965932

P698

Q37790840-D9CD5396-46D0-4AF1-8E7E-1379A776C73E

P356

1087054710381232

P1433

Journal of Attention Disorders

P1476

Changes in emotions related to ...... Part II: clinical approaches.

@en

P2093

Ann C Childress

http://www.w3.org/2001/XMLSchema#string

Frank A López

http://www.w3.org/2001/XMLSchema#string

Matthew Brams

http://www.w3.org/2001/XMLSchema#string

Michael J Manos

http://www.w3.org/2001/XMLSchema#string

Robert L Findling

http://www.w3.org/2001/XMLSchema#string

P2860

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

Confirmatory factor analysis of the Behavior Rating Inventory of Executive Function (BRIEF) in a clinical sample

Psychometric properties of the Vanderbilt ADHD diagnostic parent rating scale in a referred population.

Emotional expression in children treated with ADHD medication: development of a new measure.

Double-blind, placebo-controlled study of single-dose amphetamine formulations in ADHD.

Stimulant rebound: how common is it and what does it mean?

A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/hyperactivity disorder.

Randomized trial of a home-based family intervention for children who have deliberately poisoned themselves.

Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study.

Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.

P304

113-121

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1087054710381232

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Peter S. Jensen

P577

2010-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46393195

http://www.w3.org/2001/XMLSchema#string

P698

20858786

http://www.w3.org/2001/XMLSchema#string